It has previously been shown that neurotensin binds to high-affinity receptors in the adenocarcinoma HT29 cell line, and that receptor occupancy leads to inositol phosphate formation. The present study was designed to investigate further the effects of neurotensin on calcium mobilization and protein kinase C (PKC) activation in HT29 cells, and to assess the role of GTP-binding proteins (G-proteins) 
INTRODUCTION
receptor activation. There is however an increasing body of evidence that one of the earliest steps in neurotensin There is now evidence that neurotensin acts as a action is an increase in cellular inositol phosphate neurotransmitter or neuromodulator in the central ner- content. This has been demonstrated in slices of brain vous system [1] and as a hormone in the gastrointestinal tissue [3] , in pituitary cells [4] , in the neuroblastoma tract [2] . Although the properties and characteristics of N El 15 cell line [5] and in the human colonic adenoneurotensin binding to its receptors on target cells have carcinoma HT29 cell line [6] .
been well documented, relatively little is known con- The stimulation of inositol phosphate production, cerning the cellular and molecular events subsequent to which seems to be the common point of neurotensin Vol. 264 Abbreviations used: EGF, epidermal growth factor; G-protein, + To whom all correspondence should be addressed.
action in several systems, is due to the activation of phospholipase C. This receptor-activated enzyme hydrolyses the plasma membrane lipid Ptdlns(4,5)P2, leading to the production of InsP2 and diacylglycerol [7] . It is now well established that these two molecules act as second messengers in the bifurcating pathway of cellular events. InsP; stimulates the release of intracellular Ca2+ from its endoplasmic reticulum pool, whereas diacylglycerol activates protein kinase C (PKC) [7, 8] . Depending on the cell system, these two signalling pathways may contribute independently or synergistically to the final cellular response [8] .
The present study was designed to investigate further the mechanisms and consequences of phospholipase C activation by neurotensin in HT29 cells. More specifically, three questions were addressed in this work. (1) Does neurotensin-induced inositol phosphate production lead to Ca2+ mobilization? This was studied both directly using the florescent probe quin 2 [9] and indirectly by measuring intracellular 45Ca2+ content under equilibrium conditions [10, 11] . (2) Is inositol phosphate production accompanied by an increase in diacylglycerol and an activation of PKC? Diacylglycerol levels were directly measured in HT29 cells by means of a sensitive and specific enzymic assay [12] . Furthermore, PKC activation was assessed by measuring epidermal growth factor (EGF) binding to HT29 cells, based on the fact that EGF receptors are present on these cells [13] and on the property of the kinase to desensitize EGF binding through EGF receptor phosphorylation [14] . (3) Is there a GTP-binding protein (G-protein) that couples the neurotensin receptor to phospholipase C activation? It is well established that agonist binding to receptors that are coupled to G-proteins is negatively modulated by guanyl nucleotides and monovalent cations [15] . Therefore the effects of these agents on the binding of neurotensin to HT29 cell membranes were investigated.
MATERIALS AND METHODS

Materials
Neurotensin was generously donated by C. Granier and J. van Rietschoten (Faculte de Medecie Nord, Marseille, France). Mouse EGF was purchased from Bethesda Research Laboratories. Monoiodo[125I-Tyr3]-neurotensin (referred to as 1251-neurotensin) was prepared at a specific radioactivity of 2000 Ci/mmol and purified as previously described [16] . 125I-EGF, at a specific activity of 1000 Ci/mmol, was purchased from New England Nuclear (Paris, France). 45Ca2+ (10- Falcon culture flasks as described [6] . Cells were detached by trypsin treatment [6] , washed in culture medium, and either frozen for binding experiments on cell homogenates or cultured for 3-5 days in 24-well Falcon plates before use in experiments with intact cells. For internal Ca2" concentration measurements with the fluorescent probe quin 2, cells were plated in Falcon Petri dishes (100 mm), the bottoms of which were covered with rectangular glass coverslips.
Measurements of intracellular Ca2" using the fluorescent probe quin 2
Variations of intracellular Ca2" concentrations were measured by a modification of the method of Tsien et al. [9] . Briefly, cells grown on glass coverslips were incubated with 50 mM-quin 2 for 30 min at 37 'C. Then the cells were washed with Hepes-buffered saline (140 mM-NaCl, 5 mM-KCl, 0.9 mM-MgCl2, 1.8 mM-CaCl2 and 25 mMHepes, pH 7.5). The slides were placed in a thermostated quartz cuvette (1 cm x 1 cm). The fluorescence of quin 2-loaded cells was measured at an excitation wavelength of 339 nm and an emission wavelength of 492 nm using a Perkin Elmer 3000 spectrofluorimeter. Measurement of cell content of 45Ca21 under equilibrium conditions Cells were preincubated at 37 'C with 45Ca2+ (4 mCi/ ml) for 8 h in Dubelcco's modified Eagle's medium without serum. Then, cells were incubated with neurotensin or tested agents at the indicated concentrations for the indicated periods of time. At the end of the incubation, the medium was removed and the cells were washed four times with phosphate-buffered saline (140 mM-NaCl/10 mM-Na2HPO4, pH 7.5) without Ca2". Intracellular 45Ca2" was extracted twice with 0.5 ml of 10 M-NaOH, and radioactivity was counted.
Measurement of intracellular inositol phosphate levels
Labelling of HT29 cells with [3H]inositol and measurements of total inositol phosphate levels were performed exactly as previously described [6] .
In experiments designed to specifically measure the active Ins (1, 4, 5) 
1251I-EGF binding experiments
Cells were incubated at 37°C for 30 min in 0.5 ml of Hepes-buffered saline (pH 7.5) with or without neurotensin or PMA at the indicated concentrations. The cells were then washed at 20°C with Hepes-buffered saline containing 0.1 % bovine serum albumin. The equilibrium binding of 1251I-EGF to intact plated cells was measured at 20°C exactly as previously described [13] . Neurotensin binding to HT29 cell membranes HT29 cell membranes were prepared as follows. Frozen cell suspensions were thawed and centrifuged for 10 min at 10000 g and resuspended in 5 mM-Tris/HCI, pH 7.5. Cells were broken by 10 repeated passages through a syringe needle. The cell homogenate was centrifuged (10 min, 10000g) and washed with 5 mM-Tris/HCl, pH 7.5. After another centrifugation, the crude cell membrane preparation was resuspended at the appropriate protein concentration in binding assay buffer (50 mM-Tris/HCl, pH 7.5/0.2 % bovine serum albumin). Protein concentrations were determined using the BioRad protein assay reagent, using the procedure recommended by the manufacturer.
Binding assays were carried out at 25°C for 20 min in 250 ,1 of binding assay buffer that contained 1251_ neurotensin, 0.05-0.1 mg ofmembrane protein and, when needed, monovalent cations, nucleotides, and unlabelled neurotensin. The binding assay buffer also contained 1 mM-lOI-phenanthroline which prevented the ligand from degrading [17] . Total, specific and non-specific binding were determined as previously described [16, 18] . The dissociation constant, Kd, and maximal binding capacity, Bmax, were derived from Scatchard analysis of either saturation experiments performed with increasing concentrations of 125I-neurotensin, or competition experiments in which varying concentrations of unlabelled neurotensin were added to a fixed concentration (0.1 nM) of 1251-neurotensin. The binding of 0.1 nM-1251-neurotensin reached equilibrium by 20-30 min (results not shown). Therefore, in all experiments binding was measured after 30 min of incubation. At 0.1 nM-1251-neurotensin, non-specific binding did not exceed 10 % of total binding. Curvilinear Scatchard plots were analysed by computer according to a two-sites model [19] .
RESULTS
Effect of neurotensin on intracellular Ca2+ levels in
HT29 cells
The addition of neurotensin to monolayered HT29 cells loaded with quin 2 caused a transient increase of fluorescence emission, reflecting a transitory increase of [Ca2+]1 (Fig. 1 ). This effect was rapid in onset and peaked after 1 min. This event was found to occur after the neurotensin-stimulated production of Ins(1,4,5)P3, as measured by means of a specific radioreceptor assay (Table 1) . Indeed, the formation of Ins(1,4,5)P3 peaked after 10-15 s and then returned to basal levels over a 2 min period. When the same cell preparation was challenged with two successive neurotensin additions of increasing concentrations, the Ca2l response to the second addition of peptide was markedly lower than the response to the first addition, thus indicating that the system became desensitized (Fig. lb) . Permeabilization of the cells with digitonin, which allows Ca2" to enter the cell freely, induced the largest observable increase in fluorescence emission. As expected, an excess of Mn2+ quenched the quin 2-emitted fluorescence. When 1o-6 M-neurotensin was added to 45Ca2"-loaded cells, there was a rapid, time-dependent decrease in intracellular 4"Ca2" content ( Fig. 2, inset) . The maximal decrease (24 %) was observed after 2 min and was followed by a slow refilling of the 45Ca2" intracellular pool. The peptide effect was concentration-dependent Vol. 264 with an EC50 of 2 nM and a maximally effective concentration of 100 nm (Fig. 2) . Treatment of the cells for 15 min with 100 ng of PMA/ml inhibited by about 500 effects of neurotensin on both intracellular 45Ca2+ levels and total inositol phosphate concentrations ( Fig. 3; Table 3 ). In contrast, PMA at 100 ng/ml produced a marked (70-80 0%) inhibition of EGF binding at low ligand concentrations (Fig. 3, Table  3 ). Indeed, in the presence of the phorbol ester, the highaffinity EGF-binding component was no longer detectable (Fig. 3) . Scatchard analysis according to a onesite model yielded the following binding parameters: Kd= 1.2 nM, Bmax = 16 fmol/106 cells.
In HT29 cells depleted of PKC by a 24 h treatment with 100 ng of PMA/ml, the phorbol ester was no longer able to inhibit 125I-EGF binding, whereas neurotensin still produced a small but significant inhibition of binding (Table 3) . In these conditions, the inhibitory effect of neurotensin was reduced by about 5000 as compared with the effect observed in control HT29 cells.
The Ca2" ionophore ionomycin slightly inhibited the binding of EGF to HT29 cells (Table 3 ). This inhibitory effect was not affected by long-term treatment of the cells with PMA and was of the same magnitude as the inhibitory effect of neurotensin in PKC-depleted cells ( Table 3) .
The amount of sn-1,2-diacylglycerol detected in lipid extracts of HT29 cells was directly proportional to the number of extracted cells between 1 x 105 and 
1251-neurotensin binding to HT29 cell homogenates
The binding of 0.1 nM-1251-neurotensin to HT29 cell membranes was inhibited in a concentration-dependent manner by Na+ and to a lesser extent by K+ and Li' (Fig.  4) . EC50 values were 40, 70 and 115 mm for Na+, K+ and Li+ respectively. Scatchard plots of neurotensin binding in the absence or in the presence of 33 and 100 mM-Na+ are shown in Fig. 5 . The binding parameters derived from these plots are shown in Table 4 . In the absence of the cation, the Scatchard plot was linear, indicating the existence of one class of high-affinity neurotensin-binding sites in HT29 cell homogenates. In the presence of 33 mm-Na', the Scatchard plot was curvilinear, and this resulted from; the conversion of 80 0 of the binding sites into a lower affinity state. At 100 mM-Na', all of the binding sites were in the low-affinity state (Fig. 5 , Table  4 IOM. At this concentration, ATP exerted no inhibitory effect on neurotensin binding (Fig. 6 ). Scatchard analysis of neurotensin binding to HT29 cell membranes in the presence of 0.1 mM-GTP yielded a curvilinear plot and showed that 600% of the high-affinity binding sites were converted into low-affinity sites (Fig. 5, Table 4 ). [6, 20] and that receptor occupancy leads to inositol phosphate formation [6] . The present work was designed variations using the fluorescent indicator quin 2 [9] showed that neurotensin (0. In our hands, the use of quin 2 to measure changes in [Ca2"], did not permit the establishment of the concentration dependency of the neurotensin effect with precision. This could in part be the consequence of the Ca2+-buffering effect of quin 2 [21] and long-lasting decrease in total cellular Ca2" content consequent to the activation of a plasma membrane ATP-dependent Ca2" pump [10, 11] . Similar effects on Ca2" content were observed here when neurotensin was incubated with HT29 cells.
The peptide response was concentration-dependent with an EC50 of 2 nm. This value is similar to the Kd (1.2 nM) of neurotensin binding to intact HT29 cells [6, 20] , but it is lower than the EC50 value (87 nM) for the peptide stimulation of inositol trisphosphate levels [6] . Inositol trisphosphate is one of the products resulting from the hydrolysis of Ptdlns(4,5)P2 by receptor-coupled phospholipase C. The other product is sn-1,2-diacylglycerol, which is the physiological activator of PKC [7, 23] . It was therefore of interest to see whether neurotensin could activate this second messenger pathway. To this end, the effect of neurotensin on EGF binding to HT29 cells was investigated. Indeed, EGF receptors, which have previously been characterized in HT29 cells [13] , can be desensitized to their own ligand through phosphorylation by direct activators of PKC such as the phorbol esters, and by receptor-mediated activation of the phospholipase C pathway by agents such as bombesin and vasopressin [14] . In the present study, PMA markedly (70-80 %) reduced EGF binding to high-affinity receptors in HT29 cells. The phorbol ester effect was abolished in PKC-depleted cells. These results are similar to those reported in other systems [14] . In contrast neurotensin only slightly (10-20 %o) inhibited the binding of EGF to its receptors and this inhibition was partially insensitive to PKC depletion. The PKC-depletion-insensitive component of inhibition appeared to be the consequence of Ca2+ mobilization, as it was mimicked by the Ca2+ ionophore ionomycin. These results suggest that neurotensin only weakly, if at all, activated PKC in HT29 cells.
This led us to investigate directly the effects of neurotensin on diacylglycerol production in HT29 cells. To this end, a highly sensitive and specific enzymic diacylglycerol assay was used [12] . No effect of neurotensin could be observed on diacylglycerol levels in HT29 cells within the limit of detection of the assay. This could result from a rapid metabolism of diacylglycerol by diacylglycerol kinase and diacylglycerol lipases, as has been observed in platelets [24, 25] . A rapid metabolism could explain the small effect of neurotensin on PKCmediated inhibition of EGF binding in HT29 cells.
It is well documented that agonist-receptor binding and activation of inositol phosphate production through the phospholipase C pathway are coupled by G-protein(s). In some tissues, the G-protein that couples receptors to phospholipase C is sensitive to pertussis toxin, while in other tissues it is insensitive to the toxin [26] . The specificity and properties of neurotensin binding modulation by monovalent cations and guanyl nucleotides in HT29 cells, as reported here, are similar to what has been observed in other systems such as brain membranes [27] and the neuroblastoma cell line N 1 El 15 [18] , and are compatible with an interaction of the neurotensin receptor with a G-protein [15] . The lack of effect of pertussis toxin on the inositol phosphate and Ca2+ responses to neurotensin suggests that this G-protein corresponds to Gp, the putative pertussis-toxin-insensitive G-protein involved in phospholipase C activation [26] . This situation is different to what has been reported in Nl El 15 cells, where the neurotensin effect on inositol phosphate production was partly inhibited by pertussis Vol. 264 toxin [5] . This suggests that the G-proteins involved in phospholipase C activation by neurotensin are different in HT29 and NlEl15 cells.
In conclusion, the present data show that neurotensin receptors in HT29 cells are coupled to phospholipase C through a pertussis-toxin-insensitive G-protein. Acti- vation of phospholipase C by the peptide leads to an increase in inositol phosphate levels, and this in turn results in Ca2" mobilization. The other branch of the bifurcating phospholipase C pathway, i.e. the activation of PKC through sn-1,2-diacylglycerol production, does not seem to be significantly operated by neurotensin. Thus Ca2" appears to be the major second messenger involved in neurotensin effects in HT29 cells. This is in agreement with the reported actions of the peptide in other systems, such as, for instance, its effects on prolactin secretion in pituitary cells [28] and on intestinal smooth muscle contractility [29] 
